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Yersinia species, as well as many other Gram-negative pathogens, use a type III secretion
system (T3SS) to translocate effector proteins from the bacterial cytoplasm to the host
cytosol. This T3SS resembles a molecular syringe, with a needle-like shaft connected to
a basal body structure, which spans the inner and outer bacterial membranes. The basal
body of the injectisome shares a high degree of homology with the bacterial flagellum.
Extending from the T3SS basal body is the needle, which is a polymer of a single protein,
YscF. The distal end of the needle serves as a platform for the assembly of a tip complex
composed of LcrV. Though never directly observed, prevailing models assume that LcrV
assists in the insertion of the pore-forming proteins YopB and YopD into the host cell
membrane. This completes a bridge between the bacterium and host cell to provide
a continuous channel through which effectors are delivered. Significant effort has gone
into understanding how the T3SS is assembled, how its substrates are recognized and
how substrate delivery is controlled. Arguably the latter topic is the least understood;
however, recent advances have provided new insight, and therefore, this review will focus
primarily on summarizing the current state of knowledge regarding the control of substrate
delivery by the T3SS. Specifically, we will discuss the roles of YopK, as well as YopN and
YopE, which have long been linked to regulation of translocation. We also propose models
whereby the YopK regulator communicates with the basal body of the T3SS to control
translocation.
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INTRODUCTION
Pathogenic Yersinia species cause human diseases ranging from
relatively mild intestinal disease for Yersinia pseudotuberculosis
and Yersinia enterocolitica (Galindo et al., 2011) to bubonic plague
for Yersinia pestis (Perry and Fetherston, 1997). Despite the dif-
ferences in disease, virulence of these Yersinia species requires
a conserved type III secretion system (T3SS) that has become
a well-established model system for this form of protein secre-
tion. Though first described in Yersinia, type III secretion is
a conserved virulence factor amongst many human pathogens
such as enteropathogenic Escherichia coli (EPEC), enterohem-
orrhagic Escherichia coli (EHEC), Salmonella sp., Pseudomonas
aeruginosa, Shigella flexneri, and Chlamydia sp., which collectively
cause significant healthcare costs annually (for recent reviews
of these organisms, see Schroeder and Hilbi, 2008; Agbor and
McCormick, 2011; Dean, 2011; Wong et al., 2011). The T3SS
has been described as a molecular syringe that delivers cytotoxic
effectors into host cells. Because this virulence mechanism is con-
served in so many pathogenic organisms, it makes an attractive
target for new therapeutics. Interfering with effective delivery of
effectors could have substantial consequences on disease pathol-
ogy and, therefore, it is important to understand how bacteria
sense cell contact in order to activate the T3SS and how both the
fidelity and kinetics of effector delivery is coordinated.
In the Yersinia, genes of the T3SS are located on a 70 kb vir-
ulence plasmid, and the expression of these genes in vitro is
controlled primarily by temperature and calcium concentration,
a phenomenon referred to as the low calcium response (LCR)
(Sample et al., 1987; Mehigh et al., 1989; Michiels et al., 1990;
Straley et al., 1993). At ambient temperature, T3SS genes are not
expressed. However, upon transfer of Yersinia cultures from 26◦C
to 37◦C in the presence of millimolar calcium, conditions rep-
resenting the mammalian host, T3SS genes are expressed at low
levels and the injectisome is built (Straley et al., 1993). Chelating
calcium from the medium in vitro causes the bacteria to undergo
growth cessation and triggers massive up-regulation of T3SS
gene expression along with secretion of T3SS substrates, known
as Yops (Yersinia outer proteins) (Brubaker and Surgalla, 1964;
Straley and Bowmer, 1986; Michiels et al., 1990; Straley et al.,
1993; Petterson et al., 1996). In vivo, cell contact triggers polar-
ized translocation of effector Yops into host cells (Rosqvist et al.,
1994; Persson et al., 1995; Petterson et al., 1996; Lee et al., 1998)
and growth cessation is thought to be overcome by additional
environmental signals (Fowler and Brubaker, 1994; Fowler et al.,
2009).
This review will focus on several factors that regulate the T3SS
from both the proximal end of the injectisome inside bacteria
and the distal end inside host cells. The Yersinia T3SS is a well-
characterized archetype for this method of protein translocation,
therefore, the data presented here will be compiled primarily
from the Yersinia species: Y. pestis and the two closely related
enteric pathogens Y. pseudotuberculosis and Y. enterocolitica. We
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will briefly review the building of the injectisome before dis-
cussing in more detail the regulation of translocation. We focus
on the roles of YopN and YopK, which have been shown to play
roles in governing substrate specificity during translocation. In
addition, YopK, YopE, and YopT have been shown to play a role
in T3SS regulation after they are injected into host cells, and those
activities will be discussed as well.
THE MAKING OF AN INJECTISOME
The “T3SS” or “injectisome” is homologous to the bacterial flag-
ellum and is composed of several components that must be
defined for the context of this review. YscC forms a ring in the
bacterial outer membrane (the OM ring), and YscD and YscJ
form a ring in the inner membrane (the MS ring). Together these
proteins create a scaffold anchored within the peptidoglycan, and
therefore, they will be referred to as scaffold proteins (Figure 1,
purple). The basal body is the portion of the injectisome that
spans the inner and outer membrane, including the scaffold
proteins (YscCDJ) as well as proteins embedded within or con-
nected to the scaffold: export apparatus (YscRSTUV Figure 1,
orange), ATPase complex (YscNKL Figure 1, blue), and C ring
(YscQ Figure 1, blue). The needle is the attached polymer of YscF
that extends from the basal body into the extracellular milieu
FIGURE 1 | Model of the injectisome. Shown is a cartoon depicting the
structural components of the Yersinia injectisome. Purple, scaffold proteins:
YscC, YscD, YscJ; Orange, export apparatus proteins: YscR, YscS, YscT,
YscU, YscV; Blue, cytoplasmic components: YscQ (C-ring) and YscN, YscL,
YscK (ATPase complex); Green, YscI (rod) and YscF (needle); Red, pore
complex: LcrV (needle tip complex) and YopB/YopD (translocation pore).
(Figure 1, green). Connecting the needle tip to the target host
cell is a hypothetical structure called the pore complex (Figure 1,
red), which is composed of LcrV at the needle tip and YopB/YopD
forming a pore in the host cell membrane. The injectisome is the
completed conduit comprised of the basal body, needle, and pore
complex that allows translocation of Yops into host cells. Though
a complete injectisome docked onto a host cell has never been
observed, Figure 1 shows a model for how these components may
be assembled.
THE BASAL BODY
The basal body formation begins with oligomerization of YscC,
which forms the OM ring that spans the outer membrane and
extends into the periplasm (Koster et al., 1997; Diepold et al.,
2010). This is in contrast with the basal body of the flagellum
which begins its assembly in the inner membrane and builds out-
ward (Erhardt et al., 2010). After the OM ring is formed, a ring
of YscD is assembled in the inner membrane and is thought to
connect the outer and inner membrane rings (Spreter et al., 2009;
Diepold et al., 2010; Ross and Plano, 2011). YscD then recruits
YscJ, which oligomerizes to complete theMS ring (Yip et al., 2005;
Hodgkinson et al., 2009; Diepold et al., 2010). With the assembly
of these structures, a basic channel through the bacterial envelope
is formed, which serves as a base for assembly of the remaining
injectisome components.
An ATPase complex composed of YscN, YscK, and YscL forms
on the cytosolic face of the basal body. YscN is the ATPase neces-
sary for the secretion of substrates by the T3SS. YscL is a negative
regulator of ATPase activity, while the function of YscK is as
yet unknown (Blaylock et al., 2006). It has, however, been sug-
gested that YscK may bridge the ATPase complex to the C ring.
YscQ is assumed to comprise the C ring in Yersinia injectisomes
based on homology to flagellar components (Driks and DeRosier,
1990; Khan et al., 1992; Kubori et al., 1997; Young et al., 2003;
Thomas et al., 2006), co-localization with YscC in the membrane
(Diepold et al., 2010) and association with the ATPase complex
(Jackson and Plano, 2000). The ATPase complex and C ring asso-
ciate with the scaffold proteins forming a nearly complete basal
body (Diepold et al., 2010).
In a separate pathway, the export apparatus, composed of inte-
gral membrane proteins YscRSTUV (Allaoui et al., 1994; Fields
et al., 1994; Minamino et al., 1994; Minamino andMacnab, 2000;
Creasey et al., 2003; Melen et al., 2003; Ghosh, 2004; Spreter et al.,
2009; Berger et al., 2010), assembles within the inner membrane
independently of the scaffold proteins (Diepold et al., 2011).
YscRST are necessary to promote the oligomerization of YscV. At
this point, the assembly pathways converge and the export appa-
ratus is recruited to YscJ in the MS ring of the scaffold (Diepold
et al., 2011). With the joining of the scaffold, ATPase complex and
export apparatus, the basal body is complete and is now capabable
of exporting secretion substrates.
THE NEEDLE AND THE “EARLY” STAGE
Upon completion of the basal body, proteins necessary for needle
assembly can be exported. We refer to this point as the “early”
stage, because only “early” substrates are translocated (Figure 2).
These include the first proteins to be secreted: YscIFPXO and
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FIGURE 2 | Progression of injectisome assembly and activation. In the
early stage, the basal body recognizes early substrates (green) for secretion.
These substrates are required for needle formation. Upon completing needle
assembly, YscU (orange) undergoes autocleavage, which triggers a substrate
specificity switch and transition to the middle stage. During this phase, YopN
associates with the basal body to allow middle substrates (red) to be
secreted, while rejecting late substrates. The middle substrates are required
to form the tip complex and translocation pores. Upon cell contact, YopN is
released from the basal body and secreted, triggering transition to the late
stage. Two models are presented to depict the late stage. In the One-step
model, the pore complex assembles at the tip of the needle to create a
continuous channel, through which late substrates (yellow) are injected.
In the Two-step model, late substrates are secreted into the extracellular
space and then interact with pore proteins. The late substrate-pore
complexes diffuse across the space and interact with the host membrane to
deliver the late substrates.
YopR (Payne and Straley, 1998, 1999; Day and Plano, 2000;
Agrain et al., 2005b; Blaylock et al., 2010). YscI is suggested
to form a rod that allows substrate passage across the inner
membrane (Allaoui et al., 1995; Sukhan et al., 2003; Marlovits
et al., 2004; Wood et al., 2008; Sal-Man et al., 2012). The nee-
dle protein YscF is then secreted through the YscI rod (Diepold
et al., 2012). Polymerization of YscF polymerizes forms the nee-
dle, which extends ∼41 nm from the bacterium in Y. pestis or
∼58 nm in Y. enterocolitica. The needle has an outer diameter
of ∼6–7 nm and an inner diameter of ∼2–3 nm (Kubori et al.,
1998; Blocker et al., 2001; Hoiczyk and Blobel, 2001; Journet et al.,
2003).
Another T3S substrate, YopR, is important in the early stages of
needle assembly (Allaoui et al., 1995; Lee and Schneewind, 1999),
though its precise role is unclear. A yopR mutant secretes YscF,
but cannot form a polymerized YscF needle (Riordan et al., 2008;
Blaylock et al., 2010). In addition, YopR was found to interact
with the ATPase protein YscN (Sorg et al., 2006) suggesting that
YopR might regulate either secretion or polymerization of YscF.
YscP participates in needle assembly by regulating needle
length (Payne and Straley, 1999; Stainier et al., 2000; Journet et al.,
2003; Agrain et al., 2005a; Mota et al., 2005) and is, therefore,
often referred to as the “ruler” protein. In support of its role in
regulating needle assembly, a yscP mutant over secretes YscF
and forms needles of indiscriminate length, while secretion of
“middle” or “late” substrates (pore complex components and Yop
effectors) is severely compromised (Edqvist et al., 2003; Journet
et al., 2003; Agrain et al., 2005a,b; Diepold et al., 2012).
YscX, YscY, and YscO are also required for export of early sub-
strates, but their precise roles are unknown. Furthermore, though
YscX and YscO are required for secretion of the early substrates,
they do not appear to be secreted from the bacterium until needle
assembly is complete (Payne and Straley, 1999; Day and Plano,
2000; Diepold et al., 2012). Some work has implicated YscO as
a chaperone escort (Evans et al., 2006; Evans and Hughes, 2009;
Ibuki et al., 2011), while data from Schneewind and colleagues
suggest that YscO facilitates YscP interaction with the basal body
during needle assembly (Riordan and Schneewind, 2008; Riordan
et al., 2008). Therefore, YscO might assist YscP in regulating nee-
dle assembly, and afterward is exported. Both YscX and YscY
associate with the export apparatus via YscV (Diepold et al.,
2012), and YscY is thought to be the chaperone required for YscX
secretion (Iriarte and Cornelis, 1999; Day and Plano, 2000). YscY
has also been shown to bind to SycD, which is a chaperone facil-
itating secretion of the middle substrates YopB and YopD. The
YscY-SycD interaction suggests a possible role for YscY in regu-
lating secretion specificity (Broms et al., 2005). It is possible that
once the needle is assembled, YscY releases YscX for secretion,
and then YscY assists in secretion of the middle substrates that
are required for the next stage of injectisome assembly.
In addition to its role in regulating needle length, YscP also
interacts with YscU in the export apparatus to mediate a sub-
strate specificity switch (Figure 2). Once the needle has reached
the appropriate length, the switch is triggered, allowing recogni-
tion ofmiddle and late T3SS substrates (YopBD and effector Yops,
respectively). YscU has both a membrane spanning domain that
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anchors it in the inner membrane and a large cytosolic domain
that is essential for substrate specificity (Allaoui et al., 1994;
Edqvist et al., 2003; Sorg et al., 2007). It is thought that a con-
served substrate specificity switch domain at the C-terminus of
YscP interacts with the cytosolic domain of YscU to trigger auto-
cleavage of YscU (Lavander et al., 2003; Agrain et al., 2005b; Sorg
et al., 2007). This autocleavage is an essential step in the progres-
sion from the “early” to the “middle” stage. yscU mutants that
cannot undergo proteolysis have severe consequences on expres-
sion and secretion ofmiddle and late Yops and are also defective in
preventing Yop secretion under restrictive conditions (+ calcium)
(Riordan and Schneewind, 2008; Bjornfot et al., 2009).
THE CALCIUM BLOCKADE
After the needle is built, and YscU undergoes proteolytic cleav-
age, the T3SS is capable of secreting middle and late substrates:
middle substrates are those comprising the pore complex, while
late substrates are the effectors that are delivered into host cells.
However, in medium containing calcium (or in the absence of cell
contact), secretion of late substrates is largely prevented due to the
action of the YopN-TyeA-YscB-SycN complex, also referred to as
the calciumplug (Yother andGoguen, 1985; Forsberg et al., 1991).
During growth of wild type Yersinia in calcium-replete medium,
secretion of early and middle T3SS substrates into the extracel-
lular milieu is readily observed, whereas the late Yops are not
released in large amounts until either calcium chelation or con-
tact with a host cell occurs (Lee et al., 1998). Therefore, we use
“middle” stage to refer to the T3SS after the completion of needle
assembly and the YscP-YscU substrate switch has been triggered,
but before contact with a host cell has been made (Figure 2).
Support for the “calcium block” model stems from observa-
tions that deletion of any of the YopN-TyeA-YscB-SycN complex
genes results in the massive secretion of both middle and late
Yops in both the presence and absence of calcium in vitro, a
defect known as a calcium blind phenotype (Forsberg et al., 1991;
Skrzypek and Straley, 1995; Day and Plano, 1998; Iriarte et al.,
1998; Jackson et al., 1998; Cheng and Schneewind, 2000; Cheng
et al., 2001; Sundberg and Forsberg, 2003). During infection of
tissue culture cells, this defect manifests as a loss of specificity
phenotype whereby Yops are secreted into the medium as well
as translocated into host cells (Boland et al., 1996; Lee et al.,
1998; Cheng and Schneewind, 2000; Cheng et al., 2001; Day et al.,
2003). TyeA binds to the C-terminal half of YopN and acts as a
negative regulator of YopN secretion, helping to maintain a secre-
tion incompetent state in the presence of calcium (Iriarte et al.,
1998; Cheng et al., 2001; Ferracci et al., 2004, 2005; Schubot et al.,
2005). YscB and SycN bind to each other in the bacterial cytosol
and then to an N-terminal region of YopN (Day and Plano, 1998;
Cheng et al., 2001). To release the YopN-TyeA block once cell con-
tact is made, YscB and SycN act as chaperones to mediate YopN
export through the injectisome.
THE “MIDDLE” STAGE AND TRANSLOCON ASSEMBLY
The “middle” stage is distinguished by the secretion of the
translocators (or “middle” Yops), which include LcrV, YopB,
and YopD. These proteins are secreted into the extracellu-
lar milieu during tissue culture infection and during in vitro
growth in calcium-replete medium (Lee et al., 1998; Cheng and
Schneewind, 2000; DeBord et al., 2001; Houppert et al., 2012),
indicating that they are secreted prior to cell contact. LcrV is
secreted and polymerizes at the distal end of the YscF needle
forming a pentameric needle tip complex (Mueller et al., 2005)
that is necessary for translocation of late substrates (Goure et al.,
2004, 2005). The pore proteins, YopD and YopB, contain one
and two transmembrane domains, respectively, and are capable
of inserting themselves into the host cell membrane (Hakansson
et al., 1993; Rosqvist et al., 1995; Hakansson et al., 1996; Neyt and
Cornelis, 1999; Montagner et al., 2011). The LcrV tip complex is
thought to act as a platform for insertion of YopB and YopD into
the host cell membrane (Goure et al., 2004, 2005; Picking et al.,
2005; Broz et al., 2007; Mueller et al., 2008), and it is through this
pore complex that late Yops are thought to be delivered. The prop-
erties and proposed functions of the pore complex proteins have
been recently reviewed (Mattei et al., 2011).
Though a complete conduit between the needle and the host
cell has never been observed, there is evidence from Yersinia
and Shigella studies to support the idea of a translocator com-
plex that connects the needle with the host membrane. First, the
YopB/YopD translocators (IpaB/IpaC in Shigella) can be isolated
from host membranes, and LcrV (IpaD in Shigella) is required for
insertion of YopB/YopD (IpaB/IpaC) (Goure et al., 2004, 2005;
Picking et al., 2005; Broz et al., 2007). Second, IpaB has been
observed on the tip of needles as part of the tip complex (Ide et al.,
2001; Olive et al., 2007; Veenendaal et al., 2007). Most recently,
YopD has been detected in purified needle preparations in an
LcrV-dependent manner (Ligtenberg et al., 2012). Furthermore,
there is a direct correlation between the length of the needle,
the distance between the bacteria and host cell, and the ability
to inject Yops: the effect of changing the length of the surface
adhesin YadA on Y. enterocolitica can be counteracted by chang-
ing the length of the needle (Mota et al., 2005). In our schematic
(Figure 2, One-step model), assembly of the translocation pore
complex at the distal end of the needle would form a complete
channel connecting the bacterium to the host cell, and this would
trigger the “cell contact signal” that releases the YopN regulatory
blockade. This signifies transition to the “late” stage, whereby the
“late” Yops (effectors) are now delivered directly into host cells.
For many years, T3SS models have depicted pore complex
formation as the final step in completing a channel between
the bacterium and the host cell (Figure 2, One-step model).
However, this hypothetical model has been recently challenged by
the demonstration that extracellular late Yops, in association with
YopB and YopD, could be translocated into host cells (Akopyan
et al., 2011; Edgren et al., 2012) (Figure 2, two-step model).
Akopyan and colleagues found that middle and late Yops were
present on the surface of Y. pseudotuberculosis cells in calcium-
replete medium, indicating that bacteria are coated with Yops
prior to host cell contact (Akopyan et al., 2011; Edgren et al.,
2012). This is in contrast to prior work showing that late Yops
were not secreted into the medium prior to cell contact (Rosqvist
et al., 1994; Sory and Cornelis, 1994; Persson et al., 1995; Lee
et al., 1998; Cheng and Schneewind, 2000; DeBord et al., 2001).
Although the observations do not rule out the one-step “conduit”
model of translocation, they do suggest that late Yops can also be
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delivered into host cells by a two-step method with an extracel-
lular intermediate step. It is possible that while middle Yops are
secreted in readily detected amounts prior to cell contact, there is
“leaky” low level secretion of late Yops, that are able to aggregate
onto the bacterial surface and associate with YopB/D transloca-
tors. Upon cell contact (or calcium depletion) the YopN blockade
is released and massive amounts of late Yops are then exported
and are readily detected. Notably, the two models are not mutu-
ally exclusive, and in both models, YopB and YopD are required
for late Yop delivery.
TRANSITION TO THE “LATE” STAGE
There is an abundance of data to support a model in which there
is a conformational change in the needle that is triggered by
external stimuli such as cell contact or calcium depletion. This
changewould be transduced to the basal body, which then triggers
release of the TyeA/YopN complex and subsequent transloca-
tion of YopN, thereby relieving its blockade on late Yop export
(Ferracci et al., 2004, 2005; Torruellas et al., 2005; Hamad and
Nilles, 2007; Davis et al., 2010). In support of this model, a
crystal structure of the YopN/TyeA complex revealed that TyeA
has a conserved C-terminal helix that could potentially inter-
act with components of the basal body (Schubot et al., 2005).
Additionally, a YopN-TyeA hybrid fusion protein expressed in
Y. pestis is completely functional for calcium sensing and Yop
secretion regulation (Ferracci et al., 2004). This suggests that
YopN binding of TyeA in itself does not block the injectisome;
rather that TyeA tethering of YopN to the basal body causes the
blockage. In further support of this, YopN mutants that consti-
tutively block secretion require the presence of TyeA, but not
chaperones YscB or SycN (Ferracci et al., 2005). This would be
consistent with a conformation change in the T3SS that releases
TyeA, thereby relieving the late Yop secretion block. Previous
work investigating needle protein YscF has shown that the needle
itself also can act as a calcium sensor, since mutations can be iso-
lated that correlate with different stages of regulation (Torruellas
et al., 2005; Davis et al., 2010). Therefore, contact with a host cell
could trigger a cascade of conformational changes throughout the
T3SS such that the information is transduced through the needle
and down to the basal body. Upon receiving the signal, the TyeA
tether is broken, which allows delivery of YopN into host cells to
relieve the block on late Yop secretion.
REGULATORS OF INJECTION: YopK, YopE, AND YopT
YopK: A REGULATOR OF TRANSLOCATION RATE
YopK was first discovered in Y. pestis by Straley and Bowmer in
a screen searching for LCR genes (Straley and Bowmer, 1986).
It was later determined that YopK (named YopQ in Y. ente-
rocolitica) is present in all three pathogenic Yersinia spp. with
a high degree of sequence homology (Fernandez-Lago et al.,
1994; Holmstrom et al., 1995a). YopK is a T3SS substrate and
has an N-terminal secretion signal within the first 10 residues
(Michiels and Cornelis, 1991; Anderson and Schneewind, 1999),
and expression of YopK is regulated by calcium and temper-
ature as are other effector Yops (Straley and Bowmer, 1986;
Holmstrom et al., 1995a). YopKwas found to be important for the
mouse model of Y. pestis infection as a yopK mutant is severely
attenuated compared to wild type (Straley and Bowmer, 1986;
Straley and Cibull, 1989; Holmstrom et al., 1995a). The yopK
mutant poorly colonizes the liver and is quickly cleared from the
spleen (Straley and Cibull, 1989). Likewise, the Y. pseudotubercu-
losis yopK mutant colonizes Peyer’s patches, but due to rapid
clearance cannot colonize the spleen (Holmstrom et al., 1995a,b).
YopK has no known enzymatic activity, and the yopK mutant
retains the ability to cause cytotoxicity and prevent phagocytosis
(Holmstrom et al., 1995a,b).
Understanding the role of YopK during infection was a chal-
lenge since it is expressed at low levels. Attempts to visualize
YopK during infection by immunofluorescence only showed a
YopK signal within bacteria near the zone of contact with the
host cell (Holmstrom et al., 1995a,b, 1997). Differential detergent
fractionation was also unable to accurately decipher YopK local-
ization as it is found in the digitonin pellet fraction containing
adherent bacteria, along with host cell membranes and organelles
(Lee and Schneewind, 1999). With the creation of a GSK tag
reporter system, Garcia et al. finally demonstrated that YopK from
Y. pestis is injected into host cells during infection (Garcia et al.,
2006). Y. pseudotuberculosis YopK translocation was also observed
recently using a β-lactamase (Bla) reporter (Thorslund et al.,
2011). Because YopK is expressed at low levels in comparison to
other Yops (Holmstrom et al., 1995a) it may be that the amount
of YopK delivered to host cells is below the limit of detection by
previous methods.
Early work found that a Y. pseudotuberculosis yopK mutant
infection induced cytotoxicity (seen as cell rounding) in host
cells more rapidly than wild type, while overexpression of
YopK resulted in a lack of cytotoxicity (Holmstrom et al.,
1997). This phenotype led researchers to investigate the pos-
sibility that YopK is involved in the regulation of transloca-
tion. Immunofluorescence microscopy on infected culture cells
revealed that a Y. pseudotuberculosis yopK mutant injects a
larger quantity of YopE and YopH into host cells, whereas
overexpression of YopK inhibits translocation of YopE and
YopH (Holmstrom et al., 1997). This suggests that the hyper-
cytotoxicity phenotype of a yopK mutant is due to an increased
concentration of YopE, a GTPase activating protein (GAP), in
host cells (Holmstrom et al., 1997; Aili et al., 2002). It was found
that YopK has no role in transcription or expression of effectors
YopE or YopH, supporting the hypothesis that YopK activity is
restricted to regulating translocation (Holmstrom et al., 1997).
Indirect measurements of translocation regulation
Shortly before the characterization of YopK by Holmstrom and
colleagues, a contact-hemolytic assay, previously utilized for pore-
forming toxins (Sansonetti et al., 1986), was modified to assess
the membrane disrupting ability of Yersinia translocator pro-
tein YopB (Hakansson et al., 1996). In this assay, red blood cells
are infected with Yersinia strains and the subsequent release of
hemoglobin provides a metric for pore formation. In addition,
differentially sized sugars were incubated with infected RBCs to
estimate the size of lyticmembrane pores formed during infection
(Bhakdi et al., 1986; Braun et al., 1987). It was shown using [C14]
sucrose that an influx of sugar into host cells occurs upon effector-
induced membrane disruption and that the influx can be blocked
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by incubation with sugar moieties larger than the membrane pore
(Bhakdi et al., 1986; Braun et al., 1987). Because mutations in
yopK (as well as yopE discussed below) gave rise to higher levels
of effector translocation, it was hypothesized that the phenotype
may be related to a change in translocation pore size. As a result,
several studies were undertaken to investigate this possibility.
Using the contact-hemolysis assay, Holmstrom and colleagues
found that a Y. pseudotuberculosis yopK mutant showed a sig-
nificant increase in hemoglobin release compared to wild type
infection of erythrocytes and that hemolysis was dependent on
the presence of YopB (Holmstrom et al., 1997). Complementation
of YopK restored wild type levels of hemoglobin release, and
overexpression of YopK also rescued the hemolytic phenotype
of a multi-Yop mutant (Holmstrom et al., 1997). Incubation of
infected erythrocytes with differentially sized sugars indicated a
wild type pore size of 2.2 nm, an increased pore size of 3.5 nm in
the absence of YopK, and a decreased pore size of >1.2 nm when
YopK was overexpressed (Holmstrom et al., 1997). While these
lytic assays do not directly measure translocation of Yops, they do
suggest that YopK can control translocation pore size, which can
in turn have an effect on translocation.
Lactate dehydrogenase (LDH) release is a common cytotox-
icity assay that is often used to measure membrane disruption
and/or cell death by detecting the concentration of cytosolic LDH
that is released into the extracellular medium. Several groups have
used this assay to test lytic pore formation as correlate of translo-
cation regulation. In contrast to the contact-hemolysis assay, the
yopK mutant had no effect on LDH release from HeLa cells or
bone marrow derived macrophages during Y. pseudotuberculosis
infection (Aili et al., 2008). This discrepancy could be due to dif-
ferences between nucleated and non-nucleated cells, or it could
reflect differences in cytoskeletal networks and actin remodeling
in various cell types.
It is not yet clear how the observed changes in “pore” size (as
determined by lytic pore formation assays) correlate with changes
in translocation levels. If the translocation pore is indeed larger,
then is the internal diameter of the needle larger to accommo-
date increased flow of effectors? Considering prevailing models in
which the translocation pore complex is connected to the basal
body through the needle, a change in the pore should trigger
compensatory changes throughout the injectisome. Another pos-
sibility is that the assays which measure pore formation do not
directly measure the pores that are actively translocating, and
instead, the results could simply reflect an altered conformation
that is perhaps less stable or more flexible, and therefore appears
larger. If the pore size is not physically larger, it may be that the
altered conformation of the pore, and by extension the rest of
the injectisome, triggers a change in the export apparatus and/or
ATPase complex such that secretion substrates are recognized and
initiated through the channel at a faster rate.
Direct measurement of translocation regulation
To better understand the mechanism by which YopK regulates
translocation, a time course infection was performed using a Bla
reporter system (Dewoody et al., 2011). This approach relies on
detection of Bla reporter fused to an effector Yop, which is injected
into host cells in a T3SS-dependent manner (Marketon et al.,
2005; Dewoody et al., 2011). Using a fluorescent Bla substrate,
translocation of the Yop-Bla reporter can be detected quanti-
tatively by flow cytometry, thus providing a direct measure of
translocation. When infections are synchronized, this approach
also affords a comparison of translocation efficiency or rate by
different strains. Measuring translocation rates with a YopM-Bla
reporter revealed that wild type Y. pestis and a yopK mutant
initiate injection with similar efficiency (Dewoody et al., 2011).
However, a difference in translocation between the two strains can
be seen as soon as 1.5 h post-infection, showing that both strains
inject the same number of cells, but theyopK strain injects more
YopM-Bla reporter per cell and does so at a faster rate (Dewoody
et al., 2011).
Observing that YopK is translocated into host cells and also
plays a prominent role in controlling the injection of other
effectors prompted the question of whether YopK performs this
regulatory function within the attached bacterium or within tar-
get cells. Injection of YopK into host cells is essential to its ability
to regulate translocation of effector Yops because a non-injectable
form of YopK (Gst-YopK) does not complement ayopK mutant
(Dewoody et al., 2011). In addition, YopK expressed solely in the
host cell can restore regulation of injection during infection with
a yopK mutant (Dewoody et al., 2011). Taken together, these
data suggest that YopK is injected into host cells, and then acts as
a strong down-regulator of translocation by transmitting a signal
back to the bacterium to slow translocation.
YopK protein-protein interactions
Given that YopK works within target cells to regulate transloca-
tion, along with the evidence suggesting that it affects pore size
or conformation, researchers began investigating whether YopK
interacts directly with the translocation pore complex. It was
shown that YopK could be immunoprecipitated with YopB from
cells infected with Y. pseudotuberculosis, providing the first evi-
dence of a direct interaction between YopK and the pore (Brodsky
et al., 2010). In another study, infection of erythrocytes with
Y. pseudotuberculosis resulted in YopK, YopB, and YopD being
pulled down from red blood cell membranes, suggesting that
they form a complex in target cell membranes (Thorslund et al.,
2011). In the same study, YopK interacted with His-tagged YopD
from bacterial supernatants, but seemingly not YopB (Thorslund
et al., 2011). Recent data regarding Y. pestis YopK is in agree-
ment with the Y. pseudotuberculosis data (Dewoody et al., 2012).
In this study, YopK was expressed from a eukaryotic expression
vector within host cells and then infected with a Y. pestis yopK
mutant. The infected cells were then lysed, and YopK along with
any interacting proteins were co-immunoprecipitated with affin-
ity purified YopK antibody. YopK, which was only present within
host cells, was able to pull down YopD but not YopB (Dewoody
et al., 2012). Collectively, these data support a model for YopK
interacting directly with YopD of the translocation pore within
the cytosol of targeted cells thereby influencing the function of
the injectisome.
YopK regulates translocation fidelity
Control of substrate fidelity from within the bacteria by YopN has
been known for quite some time (Brubaker and Surgalla, 1964;
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Michiels et al., 1990; Rosqvist et al., 1994; Persson et al., 1995;
Boland et al., 1996; Day and Plano, 1998; Cheng and Schneewind,
2000; Cheng et al., 2001). A yopN mutant aberrantly secretes
and injects both middle and late Yops during infection (Boland
et al., 1996; Cheng and Schneewind, 2000). Recent work in our
lab has revealed a similar but distinct phenotype for the Y. pestis
yopK mutant (Dewoody et al., 2012). These studies build upon
an earlier observation that showed, using immunofluorescence,
that the middle substrate, YopD, is injected into host cells by a
yopK mutant (Francis and Wolf-Watz, 1998). By fractionating
infected cells and immunoblotting for a series of Yops represent-
ing early, middle, and late T3SS substrates, we found that both
middle (LcrV, YopD, and YopB) and late (YopE, YopH, YopM, and
YopN) Yops are injected into host cells, while normal rejection of
early substrates (YopR and YscF) is maintained. This observation
was confirmed through the use of middle Yop reporters, which
were created by fusing Bla to YopD and YopB. We found that
YopD-Bla and YopB-Bla are injected by the yopK mutant, but not
by wild type or the yopE mutant (Dewoody et al., 2012), which
is in agreement to previous work (Francis and Wolf-Watz, 1998).
Thus, it appears that like YopN, YopK is also required to maintain
fidelity of translocation such that only late Yops are delivered into
host cells.
The phenotype of a yopK mutant injecting middle substrates
into host cells is quite novel and indicates that YopK is a bifunc-
tional protein capable of regulating fidelity as well as rate of Yop
injection. Importantly these properties of YopK are distinct and
genetically separable, since a point mutation (YopKD46A) abol-
ishes the ability of YopK to control the rate of late Yop delivery
but is still able to inhibit injection of middle Yops (Dewoody
et al., 2012). Notably, though the YopKD46A mutant is not able
to regulate late Yop injection, it is still able to associate with
YopD and therefore presumably maintains an interaction with
the translocation pore (Thorslund et al., 2011; Dewoody et al.,
2012). Furthermore, although expression of YopK within host
cells can complement the yopK mutant in trans, by lowering the
injection levels of late Yops, it cannot prevent injection of mid-
dle Yops. Together these data indicate that the two functions of
YopK are genetically and spatially distinct. We currently favor a
model in which YopK interacts with the basal body during the
“late” stage in order to ensure that only late Yops travel through
the injectisome (Figure 3A).
As YopK is itself injected at low levels into host cells, its appear-
ance within the host cytosol and localization to the translocation
pore could provide a negative feedback signal to down-regulate
further effector delivery (Figure 3B). Why provide such a nega-
tive feedback signal? Perhaps this would provide an external cue to
initiate detachment from the host cell, which could facilitate dis-
semination and subsequent re-colonization in vivo. Additionally,
it would be prudent to prevent over-injection of cytotoxic effec-
tors, since that would likely cause an early inflammatory response,
which could be counterproductive to disease progression. In sup-
port of this, yopK mutants are known to have colonization and
dissemination defects (Straley and Bowmer, 1986; Straley and
Cibull, 1989; Holmstrom et al., 1995a,b). Furthermore, a Y. pseu-
dotuberculosis yopK mutant triggers caspase-1 and inflammasome
activation (Brodsky et al., 2010), while a Y. pestis yopK mutant
FIGURE 3 | Models for YopK functions. (A) Controlling fidelity. During the
middle stage, YopN is associated with the basal body to prevent premature
release of late substrates. This blockade is released upon cell contact by
translocating YopN into host cells. YopK now associates with the basal body
to prevent aberrant injection of middle substrates. (B) An OFF switch.
During the late stage, YopK is injected into the host cell and acts to
down-regulate injection of the other late substrates. Two models are shown
to depict how this may happen. In the Signal transduction model, YopK
would interact with the pore complex and cause a conformational change in
the pore, which then triggers structural changes along the length of the
injectisome to provide a signal to the basal body. Further transport of late
substrates is then inhibited. In the Plug model, such structural changes are
not necessarily induced. Rather, YopK binding to the pore causes a physical
blockade to the channel such that substrates cannot pass through the pore.
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causes increased apoptosis and death of alveolar macrophages
(Peters and Anderson, 2012).
How might YopK down-regulate late Yop injection? We envi-
sion two basic options for YopK activity within host cells: (1)
YopK binds to the translocation pore to trigger conformational
changes that influence substrate recognition and/or transport by
the basal body (Figure 3B, signal transduction model), (2) YopK
binds to the translocation pore and acts as a plug to block the
channel and prevent further late Yop translocation (Figure 3B,
plug model). If YopK acts as a plug, then one would predict that
mutations abolishing YopK function would also abolish YopK
binding to the pore proteins. The combined observations that
YopK can bind to the translocation pore component YopD, and
that the YopKD46A mutant loses the ability to control late Yop
injection without losing its association with YopD, suggest that
YopK binding to YopD might create a structural change in the
pore complex that is transduced to the bacterial side of the injec-
tisome. Much more work is necessary to understand how YopK
performs its two regulatory functions, and in doing so, it may be
possible to determine whether an analogous regulator exists in
other organisms.
YopE: THE GTPase ACTIVATING PROTEIN
YopE is one of the best characterized of the effector Yops, per-
haps because it is one of the most highly translocated into
host cells and is essential to virulence (Straley and Cibull, 1989;
Lee et al., 1998). YopE is highly cytotoxic as seen by a char-
acteristic cell rounding as soon as 15 minutes post-infection
(Straley and Cibull, 1989; Rosqvist et al., 1991). Cell rounding
is caused by disruption of the host cell cytoskeleton, in par-
ticular the actin microfilaments in stress fibers (Rosqvist et al.,
1991). In addition to causing cell rounding, the actions of YopE
on the cytoskeleton also serve to immobilize the cells and pre-
vent phagocytosis. YopE acts as a GAP by maintaining specific
GTPases in an inactive, or GTP-hydrolyzed, state using the con-
served arginine finger motif associated with such domains (Black
and Bliska, 2000; Von Pawel-Rammingen et al., 2000). Small
Rho GTPases RhoA, Rac1, and Cdc42 are inactivated by YopE
in vitro, although Cdc42 does not seem to be a target in vivo
(Black and Bliska, 2000; Aili et al., 2006). During infection, the
cytosolic pool of activated RhoG and Rac1 is quickly depleted
when infected with Y. pseudotuberculosis expressing YopE (Wong
and Isberg, 2005; Mohammadi and Isberg, 2009). In addition
to its anti-phagocytosis role, YopE is also implicated in control-
ling pore formation and regulating translocation, and these are
all thought to involve actin regulation. Each topic is addressed
below.
Anti-phagocytosis
YopE plays several roles in the host cell in addition to (or due
to) actin regulation. Because yersinae proliferate extracellularly,
it is essential to block phagocytosis after contact with host cells.
Y. pseudotuberculosis YopE was shown to play a role in preventing
engulfment by macrophages (Rosqvist et al., 1990). To assess the
role of GAP activity in phagocytosis, a mutation of the essential
arginine residue (YopER144A) was evaluated. Although YopER144A
was translocated efficiently, it could not prevent phagocytosis by
HeLa cells (Black and Bliska, 2000). This indicates that YopE’s
GAP activity is essential for its anti-phagocytic activity.
Inhibition of lytic pore formation
Another facet of YopE’s function is the ability to inhibit the for-
mation of lytic pores. Several groups have shown that infection
with a Y. pseudotuberculosis yopE mutant released more LDH
from HeLa cells than did a wild type infection, and that the phe-
notype was dependent on the GAP domain of YopE (Viboud and
Bliska, 2001; Aili et al., 2006, 2008; Viboud et al., 2006; Mejia et al.,
2008). In contrast to LDH release assays, a contact-hemolysis
assay showed Y. pseudotuberculosis yopE caused hemoglobin
release similar to wild type infection (Holmstrom et al., 1997).
Interestingly, as noted above the same assays performed on yopK
mutants also yielded contrasting results, but in the case of yopK, it
was the hemolysis assay that showed a phenotype. The difference
in phenotypes may be related to differences in the cytoskeleton
of each cell type, as RBCs and epithelial cells have different actin
cytoskeletal networks (Nans et al., 2011). These observations sup-
port the idea that YopE and YopK work by different mechanisms
within host cells to control translocation pores.
To further analyze the role of YopE GAP activity in lytic
pore formation, Viboud et al. transfected HeLa cells with con-
stitutively active forms of RhoA or Rac1 that cannot hydrolyze
bound GTP. When HeLa cells were transfected with activated
GTPases before infection, ectopic expression of YopE could no
longer complement the yopE mutant and resulted in high LDH
release (Viboud and Bliska, 2001). Thus, constitutively active
GTPases in the host cell blocked the ability of YopE to func-
tion. Additionally, actin regulation was found to be important
for the lytic pore inhibition, since the presence of actin poly-
merization inhibitors cytochalasin D and latrunculin B blocked
LDH release during infection with the yopE mutant (Viboud
and Bliska, 2001). Similar results were found with Clostridium dif-
ficile ToxB, an inhibitor of Rho, Rac, and Cdc42 GTPases (Mejia
et al., 2008). Taken together, these data suggest that deactivation
of small GTPases and disruption of host cell actin are essential to
the mechanism by which YopE blocks lytic pore formation in host
cell membranes.
Translocation regulation
yopE mutant strains have been shown to over-inject Yops into
host cells during infection. Fractionation of infected cells has
shown that a Y. pseudotuberculosis yopE mutant injects higher
levels of YopH, and the corresponding YopER144A GAP mutant
over-injects both YopH and YopE, (Aili et al., 2006, 2008; Isaksson
et al., 2009). In Y. pestis, YopE was shown to regulate translocation
using the YopM-Bla reporter (Dewoody et al., 2011). A yopE
mutant showed an approximately 50% increase in YopM-Bla
injection compared to infection with wild type. This pheno-
type is dependent on YopE’s GAP ability as ectopic expression
of YopER144A could not complement the yopE parent strain
(Dewoody et al., 2011).
In summary, YopE plays a role in three major aspects of
Yersinia infection: anti-phagocytosis, repression of lytic pore for-
mation, and translocation regulation. Each of these processes
depends on small Rho GTPase deactivation and thus inhibition of
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actin polymerization. What has yet to be determined is whether
one of these roles is the major function of YopE or if each is
essential for infection. Furthermore, since there is no evidence
for YopE binding directly to the translocation pore complex, any
affect it has on the injectisome pore and translocation must be
indirect. Finally, direct evidence for connections between YopE,
the actin cytoskeleton, and changes to the injectisome have yet to
be revealed.
YopT: THE CYSTEINE PROTEASE
YopT was first discovered in Y. enterocolitica as an effector that
was translocated into host cells where it disrupted actin stress
fiber and caused cytotoxicity (Iriarte and Cornelis, 1998). It is
expressed in most Y. enterocolitica and Y. pestis strains, but only a
portion of Y. pseudotuberculosis strains (Viboud and Bliska, 2001;
Aepfelbacher, 2004; Viboud et al., 2006). YopT is dispensable
for infection of Peyer’s patches by Y. enterocolitica, and a yopT
mutant shows a slight increase in virulence (Iriarte and Cornelis,
1998; Trulzsch et al., 2004). YopT is not necessary for Y. pseudo-
tuberculosis infection, but can partially restore the virulence of a
yopE mutant, suggesting some degree of redundancy between
the two cytotoxins (Viboud et al., 2006). This redundancy may
reflect the fact that both proteins target small Rho GTPases for
inactivation, albeit through different methods. Though no direct
role for YopT in translocation has been shown, its activity on the
host cytoskeleton suggests that, like YopE, it contributes to the
regulation of Yop injection.
Anti-phagocytosis and lytic pore inhibition
YopT is a cysteine protease and shares the conserved invariant
C/H/D residues necessary for proteolytic function (Shao et al.,
2002). During infection, YopT cleaves the prenyl modifications
of membrane-bound RhoA, RhoG, Rac, and Cdc42. Proteolysis
releases the GTPases from the membrane thereby disrupting
actin structures such as stress fibers and phagocytic cups (Iriarte
and Cornelis, 1998; Zumbihl et al., 1999; Grosdent et al., 2002;
Aepfelbacher et al., 2003). Infections with Y. enterocolitica strains
expressing YopT have shown that activated RhoA is released from
the host membrane (Zumbihl et al., 1999; Sorg et al., 2001).
Therefore, like YopE, YopT functions to disrupt actin regulation.
In addition, YopT creates a pool of activated GTPases located in
the nucleus (Shao et al., 2002, 2003; Aepfelbacher et al., 2003;
Wong and Isberg, 2005; Mohammadi and Isberg, 2009). The sig-
nificance of this during infection is unknown; however, it cannot
be essential, as yopT mutants do not have a virulence defect in vivo
(Iriarte and Cornelis, 1998; Trulzsch et al., 2004; Viboud et al.,
2006).
Due to its ability to regulate host actin regulation, it is not sur-
prising that YopT has a role in preventing phagocytosis and lytic
pore formation. Expression of Y. pseudotuberculosis YopT alone is
able to significantly reduce LDH release and lytic pore formation
of infected HeLa cells (Viboud et al., 2006). YopT is also able to
rescue the LDH release phenotype of a yopE mutant, but not
when activated Rho or Rac are expressed in host cells (Viboud
and Bliska, 2001). This indicates that while YopT and YopE func-
tion by distinct mechanisms, there is overlap of the resultant actin
regulation phenotypes.
Inhibition of phagocytosis by YopT was measured using both
a gentamicin protection assay and double immunofluorescence
staining. Expression of YopT in a yopEHJT Y. pseudotubercu-
losis background resulted in a small decrease in phagocytosis
when expressed at native levels and larger inhibition when over-
expressed (Viboud et al., 2006). In either case, the anti-phagocytic
effect of YopT was not as potent as that of YopE (Viboud
et al., 2006). Interestingly, infection of macrophage lines with
a Y. enterocolitica yopT mutant resulted in phagocytosis well
above that of wild type and not significantly different from a
yopEmutant (Grosdent et al., 2002). In fact, when bacteria were
opsonized before infection, the yopE mutant had no affect on
phagocytosis while the yopT mutant showed significantly more
internalization (Grosdent et al., 2002). The reasons for the dif-
ferences in observed phenotypes are not entirely clear; however,
as with observations regarding pore formation with yopK and
yopE mutants, the host background plays a confounding role in
the functions of these proteins. Given that different eukaryotic
cell types lead to different phenotypes for these mutants, future




Translocation of effectors by the T3SS is tightly regulated to opti-
mize the infectious process of disease. It is well-established that
YopN functions prior to cell contact in order to prevent the pre-
mature release of late Yops into the medium, thereby providing
a measure of fidelity to substrate recognition by the T3SS. New
data discussed here demonstrates that YopK also acts as a regula-
tor of fidelity by preventing the export of middle Yops into host
cells. How YopN and YopK coordinate these regulatory activities
is unclear. Future endeavors will need to determine whether YopN
and/or YopK are physically associated with the basal body and if
so, with which proteins do they interact and are those interac-
tions indeed required to regulate substrate specificity before and
after cell contact? Likewise, YopK and YopE are both major reg-
ulators of translocation that function after they are injected into
the host cell. YopE appears to exert its effect via manipulation of
the actin cytoskeleton, while YopK associates with the transloca-
tion pore complex. How cytoskeletal changes influence the T3SS
function, and whether these changes are channeled through the
YopK-pore complex interaction is a mystery. Understanding the
hierarchy and mechanisms of translocated regulatory proteins is
an exciting new component of T3SS research.
THE TWO-STEP TRANSLOCATIONMODEL
A new model for Yop translocation has been suggested recently:
the “two step” translocation model (Akopyan et al., 2011; Edgren
et al., 2012). In this model, middle and late Yops can be secreted
via the T3SS and subsequently associate with the bacterial outer
membrane where they aggregate into complexes of transloca-
tors and effectors. These complexes would have to be released
from bacteria, diffuse across the space between the bacterium
and host cell, and then interact with membranes of target cells.
Translocators YopB and YopD would then mediate transfer of the
effector Yops into the host cell. In support of this model, Yops
Frontiers in Cellular and Infection Microbiology www.frontiersin.org February 2013 | Volume 3 | Article 4 | 9
Dewoody et al. Regulating Yop injection
have been known to autoaggregate to the bacterial surface when
triggered after secretion in vitro (Darveau et al., 1980; Straley and
Brubaker, 1981; Bolin et al., 1982; Yother and Goguen, 1985). In
fact, the binding of Yops to the surface of the bacterium before
the T3SS was discovered led researchers to believe Yops were
outer membrane proteins and hence their name, Yersinia outer-
membrane proteins. It has also been shown that host cells can
take up YopH-Bla coated on the surface of a yopH Y. pseu-
dotuberculosis mutant (Akopyan et al., 2011). Interestingly, the
presence of the T3SS was necessary for this translocation to occur
despite the fact that YopH-Bla was not expressed in the bacteria.
This new “two step” model presents an interesting conundrum
to the Yersinia field and to the research presented herein. Several
questions remain unanswered. Do both methods of Yop delivery
occur, and if so, which one is predominant in vivo? If the nee-
dle is not connected to the host as a continuous channel, then
how is cell contact sensed in order to provide the critical signal
to release the YopN regulatory blockade on late Yop secretion? If
the injectisome is not involved in direct translocation of effectors
into host cells, how are Y. pestis effectors YopK and YopE transmit-
ting signals back to the bacteria? Do complexes of effector-Yops
and translocator-Yops form pores that are subject to regulation
by YopK, YopE, and YopT? It is difficult to envision a scenario
in which a two-step delivery method would be compatible with
the regulatory roles that YopK, YopE, and YopT seem to have
within host cells. Data presented herein strongly implicate these
bacterial effectors in generating a feedback signal that originates
within host cells, which in turn implies that there is a continuous
channel whose ends are able to communicate and exact precise
control over the timing, specificity, and amplitude of Yop deliv-
ery. Of course such a channel remains hypothetical, and future
work needs to place an emphasis on developing tools to allow
visualization of actively translocating injectisomes docked onto
host cells, as well as a more detailed view of the pore complex
architecture. Such technological advances are crucial for provid-
ing insight into these key aspects of injectisome assembly and
function.
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